BIO Statement on Confirmation of Ms. Seema Verma

March 13, 2017

BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access to medicines and continued innovation.

Discover More

BIO Statement on Veto of Prescription Drug…

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB)…

Learn more

BIO Statement on Resignation of FDA Commissioner…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the resignation of FDA Commissioner Marty Makary.“Dr. Makary inherited an FDA in crisis after the DOGE…

Learn more

BIO Launches “The Fight of Our Lives,” a National…

WASHINGTON, DC – Today, the Biotechnology Innovation Organization (BIO) announced the launch of The Fight of Our Lives, a new national campaign focused on the stories behind biotechnology breakthroughs, the patients whose lives depend on them…

Learn more